Covid-19 Update Debate
Full Debate: Read Full DebateDepartment: Department of Health and Social Care
Caroline Nokes
Main Page: Caroline Nokes (Conservative - Romsey and Southampton North)Department Debates - View all Caroline Nokes's debates with the Department of Health and Social Care
(3 years, 4 months ago)
Commons ChamberRead Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Nadhim Zahawi
The hon. Gentleman attends the Friday briefings that I offer colleagues. He is absolutely right. Last week, Public Health England published some encouraging real-world data that showed that two doses of the vaccines offer around 74% protection for those who are immunosuppressed or immunocompromised. That comes with a caveat that that group of people is not homogenous and we need to unpack some of the data. The JCVI has already recommended in its interim advice on the booster campaign in September that that group goes top of the list for the third dose as a boost. Of course, we have a large clinical trial, which will report imminently on the immunosuppressed and the immunocompromised. We will look at that data with the JCVI. The chief medical officer continues to ask the JCVI to look at what else we can do to protect that group, including through the therapeutics taskforce, which is doing some tremendous work.
Caroline Nokes (Romsey and Southampton North) (Con) [V]
There is some real concern among my constituents that they might in some way have the wrong batch of AstraZeneca vaccine. My hon. Friend provided a useful update on Friday, but can he give any further reassurance that no British traveller will be turned away at the border because they have been given the wrong vaccine?
Nadhim Zahawi
My right hon. Friend is right that there is no such thing as a wrong batch of Oxford-AstraZeneca vaccine in the United Kingdom. Our independent regulator regulates all manufacturing sites for AstraZeneca, Pfizer and the other vaccines. The AstraZeneca vaccine produced in the Serum Institute is the same vaccine—the Vaxzevria vaccine brand that is approved by the MHRA and the European Medicines Agency. There was some confusion in parts of world such as Malta last week, which the MHRA, the EMA and the Commission helped to clear up. I reassure my right hon. Friend that anyone who has had an Oxford-AstraZeneca vaccine and has the UK app or the letter to demonstrate their vaccination can travel. I think that 33 countries now recognise our vaccine certification.